Pathstone Holdings LLC Has $1.41 Million Holdings in Waters Co. (NYSE:WAT)

Pathstone Holdings LLC grew its holdings in Waters Co. (NYSE:WAT) by 1.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,916 shares of the medical instruments supplier’s stock after purchasing an additional 65 shares during the period. Pathstone Holdings LLC’s holdings in Waters were worth $1,409,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in WAT. Price T Rowe Associates Inc. MD increased its stake in shares of Waters by 0.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 80,313 shares of the medical instruments supplier’s stock worth $27,647,000 after acquiring an additional 535 shares during the last quarter. B. Riley Wealth Advisors Inc. raised its position in Waters by 29.4% during the first quarter. B. Riley Wealth Advisors Inc. now owns 1,712 shares of the medical instruments supplier’s stock valued at $589,000 after acquiring an additional 389 shares in the last quarter. Tidal Investments LLC lifted its stake in Waters by 61.6% in the first quarter. Tidal Investments LLC now owns 6,584 shares of the medical instruments supplier’s stock valued at $2,267,000 after acquiring an additional 2,509 shares during the last quarter. Swedbank AB bought a new stake in Waters in the first quarter worth approximately $10,106,000. Finally, Cetera Investment Advisers increased its stake in shares of Waters by 310.2% during the 1st quarter. Cetera Investment Advisers now owns 4,635 shares of the medical instruments supplier’s stock worth $1,596,000 after purchasing an additional 3,505 shares during the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Stock Performance

WAT opened at $386.57 on Friday. The stock has a market cap of $22.95 billion, a PE ratio of 36.89, a P/E/G ratio of 7.10 and a beta of 0.97. Waters Co. has a 1 year low of $273.60 and a 1 year high of $395.44. The stock’s 50 day simple moving average is $357.28 and its 200-day simple moving average is $332.98. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14.

Waters (NYSE:WAT) last released its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.25. The company had revenue of $740.30 million during the quarter, compared to the consensus estimate of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period last year, the firm earned $2.84 EPS. Sell-side analysts forecast that Waters Co. will post 11.79 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on WAT shares. Sanford C. Bernstein lifted their price objective on shares of Waters from $345.00 to $360.00 and gave the company a “market perform” rating in a research note on Monday, November 4th. TD Cowen raised their target price on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their target price on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Cfra set a $389.00 price target on Waters in a research report on Thursday, October 17th. Finally, Leerink Partnrs upgraded Waters from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $365.85.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.